Skip to main content
Equibles

Legato Capital Management LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1442641 San Francisco, CA
Back to AXSM Full portfolio

Position in AXSM

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$4,563,491
+$1,937,259 QoQ
Shares Held
18,644
+20.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
12 quarters on record

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legato Capital Management LLC holds $78,908,724 across 38 Biotechnology names. AXSM ranks #5 (5.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MIRM
Mirum Pharmaceuticals, Inc.
 58,512 $6,849,999
2 RVMD
Revolution Medicines, Inc.
 33,042 $6,188,105
3 TVTX
Travere Therapeutics, Inc.
 87,833 $4,989,792
4 LGND
Ligand Pharmaceuticals Inc
 15,569 $4,921,205
5 AXSM
Axsome Therapeutics, Inc.
This page 		18,644 $4,563,491
6 PVLA
Palvella Therapeutics, Inc.
 23,490 $3,589,741
7 CORT
Corcept Therapeutics Inc
 41,186 $3,581,122
8 ELVN
Enliven Therapeutics, Inc.
 64,769 $3,287,026

All Filings in AXSM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,563,491 18,644
2026-03-31 $2,626,232 15,538
2025-12-31 $1,758,275 9,627
2025-09-30 $613,443 5,051
2025-06-30 $448,981 4,301
2025-03-31 $1,164,084 9,981
2024-03-31 $377,693 4,733
2023-12-31 $686,224 8,622
2023-09-30 $602,591 8,622
2023-06-30 $858,870 11,952
2023-03-31 $433,425 7,027
2022-12-31 $541,992 7,027